SymbolMRVL
NameMARVELL TECHNOLOGY, INC.
SectorTECHNOLOGY
RegionNorth America
IndustrySemiconductors
Address1000 N. WEST STREET,SUITE 1200, WILMINGTON, Delaware, 19801, United States
Telephone+1 302 295-4840
Fax
Email
Websitehttps://www.marvell.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001835632
Description

Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.

Additional info from NASDAQ:
Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.

2026-08-19 12:25

(99% Neutral) MARVELL TECHNOLOGY, INC. (MRVL) Announces Business Combination

Read more
2026-08-18 00:59

Director MURPHY MATTHEW J 🔴 sold 7.5K shares of Marvell Technology, Inc. (MRVL) at $236.08 ($1.8M) Transaction Date: Aug 17, 2026 | Filing ID: 057525

Read more
2026-08-17 21:20

📋 Matthew Murphy (Officer) plans to sell 22K shares of Marvell Technology, Inc. (at $234.33 each, total $5.3M) Filed: Aug 17, 2026 | ID: 000520

Read more
2026-08-17 20:45

Scarpulla Justin 🟡 adjusted position in 1.6K shares (1 derivative) of Marvell Technology, Inc. (MRVL) at $222.02 Transaction Date: Aug 15, 2026 | Filing ID: 057399

Read more
2026-08-05 09:00

Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X

Read more
2026-08-04 13:00

Marvell Advances AI Memory Infrastructure Portfolio to Accelerate Agentic AI Inference

Read more
2026-08-03 20:33

Koopmans Chris 🔴 sold 10.0K shares of Marvell Technology, Inc. (MRVL) at $180.50 ($1.8M) Transaction Date: Aug 03, 2026 | Filing ID: 051905

Read more
2026-08-03 20:19

📋 KOOPMANS FAMILY TRUST U/A DTD 03/28/2013 (Officer) plans to sell 10K shares of MARVELL TECHNOLOGY, INC. (at $180.50 each, total $1.8M) Filed: Aug 03, 2026 | ID: 007514

Read more
2026-08-03 20:05

Marvell Technology, Inc. Announces Conference Call to Review Second Quarter of Fiscal Year 2027 Financial Results; Announces Investor Day on October 6, 2026

Read more
2026-08-03 13:00

Marvell to Showcase Advanced AI Memory and Storage Infrastructure Portfolio for Agentic AI Inference at FMS 2026

Read more